Share on facebook
Share on twitter
Share on linkedin
Share on telegram
Share on whatsapp

Japan’s Kowa Says Ivermectin Shows “Antiviral Effect” Against Omicron, Other Variants, in Phase III Trial

Japanese trading and pharmaceutical company Kowa announced on Monday (Jan. 31) that ivermectin showed an “antiviral effect” against Omicron and other variants of SARS-CoV-2 in joint non-clinical research.

UPDATE – Reuters has updated the title and the content of the article after initial publishing. Now says ivermectin showed “antiviral effect” instead of “effective” against Omicron.

The firm has been working with Kitasato University, a medical university in Tokyo, on testing the efficacy and safety of ivermectin 0.3-0.4 mg/kg orally administered once daily for 3 days will be evaluated in patients with mild COVID-19 using a randomized, double-blind, parallel-group comparative method with placebo as a control.

The clinical trials are still ongoing.

    Joe Biden: Pandemic is Over

    Joe Biden during an interview on 60Minutes says he believes the COVID pandemic is Over. 850 more unvaxxed NYC teachers, aides fired for not complying

    Lockdowns Harms Impossible to Cover Up

    “According to a recent study by the World Bank, published in the journal Nature, lockdowns and the response to Covid-19 have pushed an additional 75

    Contagious Vaccines: A Warning

    Brownstone Institute – For two decades scientists have been quietly developing self-spreading contagious vaccines. The NIH funded this research, in which either DNA from a deadly

    VAERS Reports as of 6/10/2022 Release

    28,859 Deaths where Vaccine is COVID19 1,301,356 Adverse Events where Vaccine is COVID19 Search Vaccine Reactions Using MedAlertsA Powerful VAERS Database Search Engine hosted by

    Would love your thoughts, please comment.x

    Get in Touch!

    Purpose of your Contact
    Where can i reach you?
    What would you like to discuss?

    Are you intending to visit the Lorphic marketing agency?